Literature DB >> 26609420

Renal tubular acidosis complicated with hyponatremia due to cortisol insufficiency.

Yuichiro Izumi1, Yushi Nakayama1, Tomoaki Onoue1, Hideki Inoue1, Masashi Mukoyama1.   

Abstract

Adrenocortical insufficiency such as occurs in Addison's disease causes hyponatremia and renal tubular acidosis (RTA). Hyponatremia results from both aldosterone and cortisol insufficiency. RTA is due to aldosterone insufficiency. The involvement of cortisol in RTA is unclear. Here, we report a woman in her 70s who was admitted to our hospital with severe hyponatremia (106 mEq/l) and RTA. The patient exhibited low plasma cortisol levels with little response to rapid adrenocorticotropic hormone loading. In contrast, the plasma aldosterone concentration was maintained at or above the normal range. Hydrocortisone replacement greatly improved both the hyponatremia and RTA. This case suggests that both aldosterone and cortisol are involved in acid secretion from the kidney.

Entities:  

Year:  2015        PMID: 26609420      PMCID: PMC4652059          DOI: 10.1093/omcr/omv063

Source DB:  PubMed          Journal:  Oxf Med Case Reports        ISSN: 2053-8855


INTRODUCTION

Hyponatremia and metabolic acidosis are major symptoms of adrenocortical dysfunction such as occurs in Addison's disease. The hyponatremia is caused by insufficiency of both aldosterone and cortisol. Aldosterone insufficiency decreases sodium reabsorption in the collecting ducts of the kidney. Cortisol insufficiency induces the secretion of antidiuretic hormone (ADH) [1, 2], resulting in syndrome of inappropriate secretion of antidiuresis (SIAD)-like conditions [3]. The metabolic acidosis is due to insufficiency of aldosterone, which decreases acid secretion in the kidney. Here, we report a patient with severe hyponatremia and metabolic acidosis that were caused by insufficiency of cortisol but not aldosterone and were successfully treated with hydrocortisone replacement.

CASE REPORT

A woman in her 70s was transferred to our hospital from a regional hospital for treatment of severe hyponatremia. The patient was drowsy and disoriented, and her blood pressure was 118/56 mmHg. Blood chemistry indicated severe hyponatremia, low serum osmolality, high urinary osmolality and sodium concentration, detectable concentration of ADH and normal serum creatinine range (Table 1). The diameter of the inferior vena cava was 4.1/13.7 mm (inspiration/expiration). Arterial blood gas indicated metabolic acidosis with a relatively low anion gap (Table 2). Endocrinological examination showed low plasma cortisol concentration with no circadian changes (Table 3). The response of the increase in cortisol to a rapid loading of tetracosactide acetate [synthesized adrenocorticotropic hormone (ACTH)] was low. Plasma renin activity was normal, and there was a relatively high plasma aldosterone concentration (PAC). Computed tomography on brain and whole body showed no abnormal findings. Taken together, we suspected that the patient exhibited a SIAD-like condition complicated with severe renal tubular acidosis (RTA) that was caused by adrenocortical insufficiency, although the PAC remained high.
Table 1:

Blood and urine data at Day 1 on admission are shown

Albumin (g/dl)3.9
Serum Na (mEq/l)106
Serum K (mEq/l)4.2
Serum Cl (mEq/l)82
Blood urea nitrogen (mg/dl)13.7
Creatinine (mg/dl)0.67
Total cholesterol (mg/dl)144
Serum osmolality (mOsm/kg·H2O)207
ACTH (pg/ml)26.1
Cortisol (μg/dl)5.9
Plasma renin activity (ng/ml/h, supine position)0.6
PAC (pg/ml)177
Antidiuretic hormone (pg/ml)2.4
BNP (pg/ml)50.6
Urine pH5.5
Urine creatinine (mg/dl)131.8
Urine Na (mEq/l)47
Urine K (mEq/l)45
Urine Cl (mEq/l)54
Urine osmolality (mOsm/kg·H2O)550
Urinary anion gap (= Na + K – Cl)38

Samples were taken at noon on supine position.

Table 2:

Arterial blood gas data

Day 1Day 19
pH7.3977.413
paCO2 (mmHg)25.330.1
paO2 (mmHg)86.7104.1
HCO3 (mEq/l)15.319.0
Base excess (mEq/l)−7.9−4.5
Anion gap (mEq/l)10.310.0

Sample was taken at room air.

Table 3:

Circadian change and response to ACTH loading of cortisol

Circadian change of cortisol
 Time7:0012:0016:0023:00
 Cortisol (μg/dl)2.73.53.02.1
 ACTH (pg/ml)22.316.716.522.0
Rapid ACTH loading
 Time after the loading (h)012
 Cortisol (μg/dl)3.310.513.8

After 250 μg tetracosactide acetate was injected intravenously, the cortisol concentration of cortisol was measured at the indicated time.

Blood and urine data at Day 1 on admission are shown Samples were taken at noon on supine position. Arterial blood gas data Sample was taken at room air. Circadian change and response to ACTH loading of cortisol After 250 μg tetracosactide acetate was injected intravenously, the cortisol concentration of cortisol was measured at the indicated time. We began fluid restriction (<500 ml/day) and intravenous drip infusion of a 1.6% NaCl solution. The patient returned to consciousness when the sodium concentration reached 111 mEq/l (Fig. 1a). The serum sodium concentration and predicted HCO3− concentration (HCO3− = Na-Cl-12) increased to 125 and 18 mEq/l, respectively, at Day 9 after admission. The serum potassium concentration gradually increased from 4.2 at Day 1 to 5.0 mEq/l at Day 12 as her diet intake recovered. Because the hyponatremia did not further improve, we prescribed hydrocortisone at 10 mg in the morning and 5 mg in the evening on Day 14.
Figure 1:

Change in physical, blood and urine data over the time course. Body weight and urine volume (b), food intake (c), serum sodium and potassium concentrations (d), predicted HCO3− concentration (e), PAC and BNP (f), urinary sodium and potassium (g), fractional excretion of sodium (h), and urine and serum osmolality (i) are plotted. Details of intravenous drip infusion and medications are indicated (a).

Change in physical, blood and urine data over the time course. Body weight and urine volume (b), food intake (c), serum sodium and potassium concentrations (d), predicted HCO3− concentration (e), PAC and BNP (f), urinary sodium and potassium (g), fractional excretion of sodium (h), and urine and serum osmolality (i) are plotted. Details of intravenous drip infusion and medications are indicated (a). On the first day of treatment, urine output increased up to 2000 ml/day and remained at 1500 ml/day thereafter. At Day 19, the serum sodium concentration increased to 138 mEq/l. The arterial HCO3− concentration was 19.0 mEq/l (Table 2). The predicted HCO3− concentration increased to 20 mEq/l (Fig. 1e). The serum potassium concentration decreased (Fig. 1d). The PAC decreased to a normal range (Fig. 1f). Because the plasma brain natriuretic peptide (BNP) level increased (Fig. 1f), we were concerned about heart failure due to volume overload by dietary intake. We therefore prescribed 10 mg/day of furosemide (Fig. 1a). The predicted HCO3− concentration was finally increased to 22 mEq/l, and the patient was discharged.

DISCUSSION

Adrenocortical insufficiency causes hyponatremia and Type IV RTA due to insufficiency of cortisol (glucocorticoid) and aldosterone (mineralocorticoid). An interesting point in the present case is that the patient exhibited low cortisol but not aldosterone concentrations, although she exhibited both hyponatremia and metabolic acidosis. Both cortisol and aldosterone are key factors that regulate serum sodium concentration. Aldosterone maintains sodium concentration by activating epithelial Na channels in the collecting duct of the kidney. The regulatory mechanism of sodium concentration by cortisol has not been sufficiently investigated. Some studies suggest that cortisol insufficiency induces ADH secretion, resulting in SIAD-like conditions [1, 2, 4]. Interestingly, administration of hydrocortisone improved the acidosis, suggesting that the glucocorticoid action of hydrocortisone should improve RTA in the present case. We were unable to classify the present case as Type IV RTA because the PAC remained high and the serum potassium concentration was not high enough to diagnose hyperkalemia. Because the metabolic acidosis was normalized with respiratory compensation, hyperkalemia may not have occurred. In addition, after the treatment of acidosis with hydrocortisone, urinary pH was still low (5.5), suggesting the absence of urinary loss of HCO3−. That result would deny the possibility of Type I and II RTA. These findings suggest that RTA in the present case was caused by cortisol insufficiency, which would not be applicable to the current classification of RTA. Cortisol and aldosterone bind to the mineralocorticoid receptor (MR) [5]. 11-Beta hydroxysteroid dehydrogenase 2 deactivates cortisol, resulting in the predominant action of aldosterone in the collecting ducts [6]. However, because the cortisol plasma concentration is 1000 times higher than that of aldosterone, cortisol might still have an effect on acid secretion in the collecting duct. A more likely interpretation is the insufficiency of ammoniagenesis by cortisol in proximal tubules [7]. Ammonia (NH3) is produced in the proximal tubules and secreted from the collecting ducts with H+. Therefore, we propose the following mechanisms regarding metabolic acidosis in the present case: (i) cortisol insufficiency induces metabolic acidosis due to insufficient acid secretion and (ii) metabolic acidosis induces mild potassium concentration increase [8]. In summary, we report a case that exhibited severe hyponatremia due to insufficiency of cortisol, but not aldosterone. Replacement of hydrocortisone improved not only hyponatremia but also RTA, suggesting the involvement of cortisol in maintaining sodium concentration and acid secretion by the kidney.

CONFLICT OF INTEREST STATEMENT

None declared.
  8 in total

Review 1.  Clinical practice. The syndrome of inappropriate antidiuresis.

Authors:  David H Ellison; Tomas Berl
Journal:  N Engl J Med       Date:  2007-05-17       Impact factor: 91.245

Review 2.  Glucocorticoid and mineralocorticoid receptors: biology and clinical relevance.

Authors:  J W Funder
Journal:  Annu Rev Med       Date:  1997       Impact factor: 13.739

3.  Renal ammoniagenic response to chronic acid loading: role of glucocorticoids.

Authors:  T C Welbourne; G Givens; S Joshi
Journal:  Am J Physiol       Date:  1988-01

4.  Symptomatic hyponatremia as a presenting sign of hypothalamic-pituitary disease: a syndrome of inappropriate secretion of antidiuretic hormone (SIADH)-like glucocorticosteroid responsive condition.

Authors:  D Olchovsky; D Ezra; I Vered; M Hadani; I Shimon
Journal:  J Endocrinol Invest       Date:  2005-02       Impact factor: 4.256

Review 5.  Glucocorticoid inhibition of neurohypophysial vasopressin secretion.

Authors:  H Raff
Journal:  Am J Physiol       Date:  1987-04

Review 6.  Acid-base and potassium homeostasis.

Authors:  L Lee Hamm; Kathleen S Hering-Smith; Nazih L Nakhoul
Journal:  Semin Nephrol       Date:  2013-05       Impact factor: 5.299

7.  Close association of severe hyponatremia with exaggerated release of arginine vasopressin in elderly subjects with secondary adrenal insufficiency.

Authors:  Toshimitsu Yatagai; Ikuyo Kusaka; Tomoatsu Nakamura; Shoichiro Nagasaka; Kazufumi Honda; Shun Ishibashi; San-e Ishikawa
Journal:  Eur J Endocrinol       Date:  2003-02       Impact factor: 6.664

8.  Minealocorticoid receptors and 11 beta-steroid dehydrogenase activity in renal principal and intercalated cells.

Authors:  A Náray-Fejes-Tóth; E Rusvai; G Fejes-Tóth
Journal:  Am J Physiol       Date:  1994-01
  8 in total
  2 in total

1.  Educational Case: Adrenocortical insufficiency-Causes and pathogenesis.

Authors:  Steven J Vance; Jacob T Horsley; Matthew P Welch; Robert D Muterspaugh; Jyotsna Pandey
Journal:  Acad Pathol       Date:  2022-05-17

2.  PES Syndrome Presenting as Severe Hyponatremia in an Asymptomatic Septuagenarian.

Authors:  Rahul Pansare; Sangeetha Nanthabalan
Journal:  Case Rep Endocrinol       Date:  2021-01-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.